Gilead Unveils New Manufacturing Site in California as Part of $32B U.S. Investment Plan

Gilead Sciences; Foster City; California; manufacturing facility; biopharmaceuticals; $32 billion investment; economic impact; expansion; R&D; job creation; U.S. manufacturing

Genentech’s $700M North Carolina Plant and Telix’s FDA CRL Update

Genentech; Roche; North Carolina; manufacturing facility; $700 million; Holly Springs; metabolic medicines; obesity treatments; biomanufacturing; Telix; FDA; Complete Response Letter (CRL); imaging agent